10x Genomics and Fred Hutch partner on cancer technologies
The initiative represents the first time 10x Genomics widened its scope past solid tumours to include haematologic malignancies.
Drug Development
Rocket receives $150m credit facility to advance cardiovascular portfolio
Gilead Sciences signs five-year DevOps agreement with Cognizant
Pacira partners with Molteni for Exparel commercialisation
AstraZeneca opens new R&D centre in Cambridge, US
FDA approves expanded indication for Lilly’s Jaypirca
Bayer plans $2.2bn pharmaceutical manufacturing facility in Ohio, US
Bristol Myers Squibb secures expanded US approval for Camzyos
